Neuroone Medical Technologies (NMTC) Convertible Debt (2017 - 2020)

Neuroone Medical Technologies (NMTC) has reported Convertible Debt for 4 consecutive years, with $1.0 million the latest figure, recorded in Q3 2020.

• For the quarter ending Q3 2020, Convertible Debt changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2020 stood at $1.0 million (changed N/A YoY), and the FY2020 full-year result was $1.0 million, changed N/A from the prior year.
• Convertible Debt slipped to $1.0 million in Q3 2020 per NMTC's latest filing, from $6.7 million in the prior quarter.
• Across five years, Convertible Debt topped out at $6.7 million in Q2 2020 and bottomed at $1.0 million in Q3 2020.
• Historically, Convertible Debt has averaged $3.1 million across 4 years, with a median of $2.2 million in 2017.
• The sharpest annual moves came in 2018 and 2019: Convertible Debt slipped 23.54% in 2018, then surged 213.2% in 2019.
• Over 4 years, Convertible Debt stood at $2.2 million in 2017, then retreated by 23.54% to $1.7 million in 2018, then soared by 213.2% to $5.2 million in 2019, then tumbled by 80.6% to $1.0 million in 2020.
• According to Business Quant data, Convertible Debt over the past three periods registered $1.0 million, $6.7 million, and $4.9 million for Q3 2020, Q2 2020, and Q1 2020 respectively.